281 related articles for article (PubMed ID: 18640389)
1. Pioglitazone administration decreases cardiovascular disease risk factors in insulin-resistant smokers.
Abbasi F; Farin HM; Lamendola C; McGraw L; McLaughlin T; Reaven GM
Metabolism; 2008 Aug; 57(8):1108-14. PubMed ID: 18640389
[TBL] [Abstract][Full Text] [Related]
2. Relationship between changes in insulin sensitivity and associated cardiovascular disease risk factors in thiazolidinedione-treated, insulin-resistant, nondiabetic individuals: pioglitazone versus rosiglitazone.
Abbasi F; Lima NK; Reaven GM
Metabolism; 2009 Mar; 58(3):373-8. PubMed ID: 19217454
[TBL] [Abstract][Full Text] [Related]
3. Pioglitazone decreases postprandial accumulation of remnant lipoproteins in insulin-resistant smokers.
Abbasi F; Lamendola C; Leary ET; Reaven GM
Diabetes Obes Metab; 2009 Aug; 11(8):779-85. PubMed ID: 19476476
[TBL] [Abstract][Full Text] [Related]
4. The relationship between insulin resistance and dyslipidaemia in cigarette smokers.
Farin HM; Abbasi F; Kim SH; Lamendola C; McLaughlin T; Reaven GM
Diabetes Obes Metab; 2007 Jan; 9(1):65-9. PubMed ID: 17199720
[TBL] [Abstract][Full Text] [Related]
5. Sibutramine effect on metabolic control of obese patients with type 2 diabetes mellitus treated with pioglitazone.
Derosa G; D'Angelo A; Salvadeo SA; Ferrari I; Gravina A; Fogari E; Maffioli P; Cicero AF
Metabolism; 2008 Nov; 57(11):1552-7. PubMed ID: 18940393
[TBL] [Abstract][Full Text] [Related]
6. Endothelial activation and inflammation in prepubertal obese Turkish children.
Süheyl Ezgü F; Hasanoğlu A; Tümer L; Ozbay F; Aybay C; Gündüz M
Metabolism; 2005 Oct; 54(10):1384-9. PubMed ID: 16154440
[TBL] [Abstract][Full Text] [Related]
7. Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians.
Raji A; Gerhard-Herman MD; Williams JS; O'connor ME; Simonson DC
Diabet Med; 2006 May; 23(5):537-43. PubMed ID: 16681563
[TBL] [Abstract][Full Text] [Related]
8. Additive effect of interleukin-6 and C-reactive protein (CRP) single nucleotide polymorphism on serum CRP concentration and other cardiovascular risk factors.
Paik JK; Kim OY; Koh SJ; Jang Y; Chae JS; Kim JY; Kim HJ; Hyun YJ; Cho JR; Lee JH
Clin Chim Acta; 2007 May; 380(1-2):68-74. PubMed ID: 17335789
[TBL] [Abstract][Full Text] [Related]
9. Association of soluble intercellular adhesion molecule-1 with insulin resistance and metabolic syndrome in Taiwanese.
Hsu LA; Ko YL; Wu S; Teng MS; Chou HH; Chang CJ; Chang PY
Metabolism; 2009 Jul; 58(7):983-8. PubMed ID: 19394054
[TBL] [Abstract][Full Text] [Related]
10. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus.
Davidson M; Meyer PM; Haffner S; Feinstein S; D'Agostino R; Kondos GT; Perez A; Chen Z; Mazzone T
Circulation; 2008 Apr; 117(16):2123-30. PubMed ID: 18413496
[TBL] [Abstract][Full Text] [Related]
11. Metabolic changes following sibutramine-assisted weight loss in obese individuals: role of plasma free fatty acids in the insulin resistance of obesity.
McLaughlin T; Abbasi F; Lamendola C; Kim HS; Reaven GM
Metabolism; 2001 Jul; 50(7):819-24. PubMed ID: 11436188
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein abnormalities are associated with insulin resistance in South Asian Indian women.
Palaniappan LP; Kwan AC; Abbasi F; Lamendola C; McLaughlin TL; Reaven GM
Metabolism; 2007 Jul; 56(7):899-904. PubMed ID: 17570249
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
14. C-reactive protein, insulin resistance and risk of cardiovascular disease: a population-based study.
Jeppesen J; Hansen TW; Olsen MH; Rasmussen S; Ibsen H; Torp-Pedersen C; Hildebrandt PR; Madsbad S
Eur J Cardiovasc Prev Rehabil; 2008 Oct; 15(5):594-8. PubMed ID: 18753952
[TBL] [Abstract][Full Text] [Related]
15. Relationship between insulin resistance, weight loss, and coronary heart disease risk in healthy, obese women.
McLaughlin T; Abbasi F; Kim HS; Lamendola C; Schaaf P; Reaven G
Metabolism; 2001 Jul; 50(7):795-800. PubMed ID: 11436184
[TBL] [Abstract][Full Text] [Related]
16. Comparison of body mass index versus waist circumference with the metabolic changes that increase the risk of cardiovascular disease in insulin-resistant individuals.
Farin HM; Abbasi F; Reaven GM
Am J Cardiol; 2006 Oct; 98(8):1053-6. PubMed ID: 17027570
[TBL] [Abstract][Full Text] [Related]
17. Effect of smoking cessation on markers of inflammation and endothelial cell activation among individuals with high risk for cardiovascular disease.
Halvorsen B; Lund Sagen E; Ueland T; Aukrust P; Tonstad S
Scand J Clin Lab Invest; 2007; 67(6):604-11. PubMed ID: 17852807
[TBL] [Abstract][Full Text] [Related]
18. Anti-inflammatory effects of pioglitazone and/or simvastatin in high cardiovascular risk patients with elevated high sensitivity C-reactive protein: the PIOSTAT Study.
Hanefeld M; Marx N; Pfützner A; Baurecht W; Lübben G; Karagiannis E; Stier U; Forst T
J Am Coll Cardiol; 2007 Jan; 49(3):290-7. PubMed ID: 17239709
[TBL] [Abstract][Full Text] [Related]
19. Rosiglitazone and pioglitazone similarly improve insulin sensitivity and secretion, glucose tolerance and adipocytokines in type 2 diabetic patients.
Miyazaki Y; DeFronzo RA
Diabetes Obes Metab; 2008 Dec; 10(12):1204-11. PubMed ID: 18476983
[TBL] [Abstract][Full Text] [Related]
20. Cigarette smoking is independently associated with markers of endothelial dysfunction and hyperinsulinaemia in nondiabetic individuals with coronary artery disease.
Winkelmann BR; Boehm BO; Nauck M; Kleist P; März W; Verho NK; Ranjith N; Kneissl G
Curr Med Res Opin; 2001; 17(2):132-41. PubMed ID: 11759183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
